Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia

for
Immune System Diseases, Eosinophilia, Helminthiasis,
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 1 - 70+

Code: NCT00001406

Recruiting

A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

for
Cancer
Location: Saint John, Montreal, Ottawa, Toronto, Hamilton,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03847649

Phase 2, Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

for
Advanced Cancer
Location: New York NY, Newark DE, Baltimore MD, Bethesda MD,
Sponsor: Riboscience, LLC.

Sex: All

Age: 18+

Code: NCT05270213

Phase 1, Recruiting

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

for
Leukemia, Myeloid Leukemia, Monocytic Leukemia
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT06429449

Phase 1, Recruiting

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

for
Neoplasms, Arteriovenous Malformation of Central Nervous System,
Location: Miami FL, Detroit MI
Sponsor: The Radiosurgery Society

Sex: All

Age: 0+

Code: NCT01885299

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

for
Breast, Metastatic, Triple Negative, Cancer,
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18 - 70+

Code: NCT04333706

Phase 1, Phase 2, Recruiting

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Baltimore MD, Whittier CA, Los Angeles CA
Sponsor: Zhejiang Haichang Biotech Co., Ltd.

Sex: All

Age: 18+

Code: NCT05267899

Phase 1, Recruiting

Active Living After Cancer: Implementation Within Be Well Acres Homes

for
Cancer, Fatigue
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06907706

Recruiting

HP Pyruvate MRI in Cancers

for
Image, Warburg Effect, Tumors
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18 - 70+

Code: NCT05697406

Phase 1, Phase 2, Recruiting

Childhood Cancer Predisposition Study (CCPS)

for
Pediatric Cancer
Location: Boston MA, Philadelphia PA, Toronto, Atlanta GA,
Sponsor: Emory University

Sex: All

Age: 0+

Code: NCT04511806

Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

for
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma
Location: Port Saint Lucie FL, Huntersville NC, Greenville SC,
Sponsor: FBD Biologics Limited

Sex: All

Age: 18+

Code: NCT05892718

Phase 1, Recruiting

Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia

for
Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 1 - 25

Code: NCT05645718

Phase 2, Recruiting

Web-based Program to Improve Self-management Among Veterans-caregiver Dyads

for
Chronic Medical Conditions
Location: Palo Alto CA
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT06001541

Recruiting

Lorlatinib Combinations in Lung Cancer

for
Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04292119

Phase 1, Phase 2, Recruiting

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Location: Boston MA, Hollywood FL, Athens GA, Columbus OH,
Sponsor: Turning Point Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT03093116

Phase 1, Phase 2, Recruiting

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

for
Refractory and/or Relapsed Metastatic Solid Tumors
Location: Valhalla NY, The Bronx NY, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 1 - 50

Code: NCT01804634

Phase 2, Recruiting

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

for
Leukemia, Myelodysplastic Syndromes,
Location: Portland ME, Providence RI, Hartford CT, Lebanon NH,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0 - 30

Code: NCT04968834

Recruiting

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

for
Bladder Cancer, Urinary Bladder Neoplasm, Urologic Neoplasms,
Location: Boston MA, Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT04442724

Recruiting

Expressive Writing for the Management of Stress in Cancer Survivors

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04776941

Recruiting

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

for
Endometrial Cancer, Endometrioid Tumor, Cancer, Tumor,
Location: Providence RI, New York NY, Miami Beach FL,
Sponsor: Aadi Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT05997017

Phase 2, Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial